TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N105 Class: COMMON STOCK

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q3 2017
Shares 1,685,451 Value ($000) $11,529 Avg Close — Range —
Q2 2017
Shares 1,572,026 Value ($000) $11,209 Avg Close — Range —
Q1 2017
Shares 1,490,747 Value ($000) $13,700 Avg Close — Range —
Q4 2016
Shares 2,325,695 Value ($000) $9,373 Avg Close — Range —
Q3 2016
Shares 2,300,705 Value ($000) $8,812 Avg Close — Range —
Q2 2016
Shares 2,471,984 Value ($000) $10,628 Avg Close — Range —
Q1 2016
Shares 1,240,801 Value ($000) $5,745 Avg Close — Range —
Q4 2015
Shares 5,012,815 Value ($000) $50,279 Avg Close — Range —
Q3 2015
Shares 4,896,987 Value ($000) $36,531 Avg Close — Range —
Q2 2015
Shares 2,651,113 Value ($000) $125,769 Avg Close — Range —
Q1 2015
Shares 2,388,136 Value ($000) $87,501 Avg Close — Range —
Q4 2014
Shares 1,634,775 Value ($000) $64,918 Avg Close — Range —
Q3 2014
Shares 1,515,122 Value ($000) $30,227 Avg Close — Range —
Q2 2014
Shares 1,543,916 Value ($000) $20,828 Avg Close — Range —
Q1 2014
Shares 1,612,896 Value ($000) $17,564 Avg Close — Range —
Q4 2013
Shares 1,751,000 Value ($000) $23,673 Avg Close — Range —